Proteome Sciences (LON:PRM) Shares Down 11% – Here’s What Happened

Shares of Proteome Sciences plc (LON:PRM) dropped 11% during mid-day trading on Friday . The stock traded as low as GBX 3 and last traded at GBX 3.13. Approximately 114,507 shares changed hands during mid-day trading, a decline of 72% from the average daily volume of 410,523 shares. The stock had previously closed at GBX 3.51.

Proteome Sciences Stock Down 14.0%

The company has a market capitalization of £8.91 million, a P/E ratio of -2.67 and a beta of 0.07. The company has a quick ratio of 0.37, a current ratio of 0.20 and a debt-to-equity ratio of -258.66. The firm has a fifty day simple moving average of GBX 2.28 and a 200-day simple moving average of GBX 2.56.

Proteome Sciences Company Profile

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.